MGO One Seven’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.33M | Sell |
138,195
-6,586
| -5% | -$172K | 0.06% | 357 |
|
|
2026
Q1 | $4.07M | Buy |
144,781
+1,605
| +1% | +$42.7K | 0.08% | 284 |
|
|
2025
Q4 | $3.57M | Buy |
143,176
+36,045
| +34% | +$909K | 0.07% | 308 |
|
|
2025
Q3 | $2.73M | Buy |
107,131
+22,968
| +27% | +$567K | 0.06% | 321 |
|
|
2025
Q2 | $2.04M | Sell |
84,163
-34,062
| -29% | -$794K | 0.07% | 317 |
|
|
2025
Q1 | $3M | Buy |
118,225
+5,987
| +5% | +$157K | 0.12% | 191 |
|
|
2024
Q4 | $2.98M | Buy |
112,238
+2,050
| +2% | +$55.6K | 0.11% | 203 |
|
|
2024
Q3 | $3.19M | Sell |
110,188
-2,867
| -3% | -$83.6K | 0.14% | 174 |
|
|
2024
Q2 | $3.16M | Sell |
113,055
-2,316
| -2% | -$63.8K | 0.15% | 152 |
|
|
2024
Q1 | $3.2M | Sell |
115,371
-5,344
| -4% | -$148K | 0.17% | 143 |
|
|
2023
Q4 | $3.48M | Buy |
120,715
+36,316
| +43% | +$1.1M | 0.2% | 124 |
|
|
2023
Q3 | $2.8M | Buy |
84,399
+5,355
| +7% | +$189K | 0.22% | 112 |
|
|
2023
Q2 | $2.9M | Sell |
79,044
-14,224
| -15% | -$554K | 0.27% | 83 |
|
|
2023
Q1 | $3.81M | Buy |
93,268
+6,639
| +8% | +$287K | 0.24% | 111 |
|
|
2022
Q4 | $4.44M | Buy |
86,629
+2,731
| +3% | +$131K | 0.44% | 42 |
|
|
2022
Q3 | $6.14M | Buy |
83,898
+18,172
| +28% | +$883K | 0.24% | 66 |
|
|
2022
Q2 | $3.45M | Sell |
65,726
-2,248
| -3% | -$115K | 0.48% | 39 |
|
|
2022
Q1 | $3.52M | Buy |
67,974
+3,745
| +6% | +$194K | 0.38% | 61 |
|
|
2021
Q4 | $3.79M | Buy |
64,229
+8,749
| +16% | +$433K | 0.39% | 54 |
|
|
2021
Q3 | $2.43M | Buy |
55,480
+391
| +0.7% | +$17.3K | 0.31% | 83 |
|
|
2021
Q2 | $2.16M | Buy |
55,089
+1,899
| +4% | +$73.8K | 0.3% | 83 |
|
|
2021
Q1 | $1.93M | Buy |
53,190
+1,918
| +4% | +$68.1K | 0.33% | 75 |
|
|
2020
Q4 | $1.89M | Sell |
51,272
-477
| -0.9% | -$17.5K | 0.39% | 58 |
|
|
2020
Q3 | $1.8M | Sell |
51,749
-7,117
| -12% | -$250K | 0.43% | 56 |
|
|
2020
Q2 | $1.83M | Buy |
58,866
+5,677
| +11% | +$193K | 0.47% | 45 |
|
|
2020
Q1 | $1.65M | Buy |
53,189
+900
| +2% | +$30.7K | 0.56% | 44 |
|
|
2019
Q4 | $1.94M | Sell |
52,289
-1,208
| -2% | -$43K | 0.51% | 48 |
|
|
2019
Q3 | $1.82M | Buy |
53,497
+1,579
| +3% | +$57.4K | 0.52% | 43 |
|
|
2019
Q2 | $2.13M | Buy |
51,918
+294
| +0.6% | +$11.7K | 0.69% | 29 |
|
|
2019
Q1 | $2.08M | Buy |
51,624
+15,643
| +43% | +$626K | 0.68% | 28 |
|
|
2018
Q4 | $1.49M | Sell |
35,981
-2,483
| -6% | -$103K | 0.64% | 23 |
|
|
2018
Q3 | $1.61M | Buy |
+38,464
| New | +$1.48M | 0.75% | 20 |
|
|
2018
Q1 | $1.3M | Buy |
38,542
+470
| +1% | +$16.2K | 0.6% | 22 |
|
|
2017
Q4 | $1.31M | Buy |
+38,072
| New | +$1.3M | 0.6% | 20 |
|
Other funds holding PFE
MGO One Seven's PFE Position: Q2 2026 in Review
MGO One Seven reduced its Pfizer (PFE) stake by 4.5% in Q2 2026, selling an estimated $172K and leaving 138,195 shares worth $3.33M. The position accounts for 0.06% of the portfolio, ranked #357.
MGO One Seven first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.14M in Q3 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MGO One Seven held 138,195 shares of Pfizer worth $3.33M as of Q2 2026.
- MGO One Seven sold 6,586 Pfizer shares in Q2 2026, an estimated $172K.
- Pfizer made up 0.06% of MGO One Seven's portfolio in Q2 2026, its #357 holding.
- MGO One Seven first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- MGO One Seven's Pfizer position peaked at $6.14M in Q3 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.